Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Directors' Dealings

8 Oct 2014 07:00

RNS Number : 7039T
Microsaic Systems plc
08 October 2014
 



Microsaic Systems plc

("Microsaic" or the "Company")

 

Directors' Dealings

 

 

08 October 2014: Microsaic Systems plc (AIM: MSYS), confirms that, further to the announcement of the Placing on 7 October 2014, Colin Nicholl, Eric Yeatman and James Ramage have subscribed for an aggregate of 296,895 Placing Shares, representing 2.8% of the Placing Shares. Immediately following admission the beneficial interests of the participating directors will be as follows:

 

 

Director

Number of Ordinary Shares held as at the date of this announcement

Number of Placing Shares subscribed for in Placing

Resulting number of Ordinary Shares held immediately following Admission

Resulting holding as a percentage of the Enlarged Issued Share Capital

Eric Yeatman

3,252,723

35,000

3,287,723

5.21%

James Ramage

261,190

23,800

284,990

0.45%

Colin Nicholl

3,030,616

238,095

3,268,711

5.18%

 

 

The Company has also been notified that on 7 October 2014 Professor Andrew Holmes, Non-Executive Director of the Company sold 100,000 Ordinary Shares at a price of 42p per Ordinary Share.

 

Following this sale, Prof Holmes holds 2,836,656 Ordinary Shares, representing approximately 4.5% of the Company's issued share capital.

 

Note that capitalised terms used in this announcement have the same meanings as in the announcement of the Placing on 7 October 2014.

Ends

 

 

 

 

Contacts

Microsaic Systems

Colin Jump, CEO

Andrew Darby, FD

Via Citigate Dewe Rogerson

 

Numis Securities Limited

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson (Financial PR)

Mark Swallow, Malcolm Robertson, Chris Gardner

 

+44 (0)20 7282 2948/2867/2995

 

 

About Microsaic Systems

Microsaic Systems Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry by integrating the key MS components onto patented chip technologies called ionchip®, spraychip® and vac-chip™. Microsaic's MS products retain the speed and sensitivity of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiD is the world's smallest MS system.

Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including government, energy, utilities, pharmaceutical, diagnostics and healthcare, environmental, food and drink, security and defence, and industrial chemicals - a combined market of $3 billion in 2012.

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS.

www.microsaic.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBLBDGSDGBGSR
Date   Source Headline
24th Nov 20222:00 pmRNSPrice Monitoring Extension
30th Sep 20227:00 amRNSHalf-year Report
13th Sep 20227:25 amRNSSupply of mass spectroscopy services to DeepVerge
22nd Aug 20227:00 amRNSPartnership with Kingfield Electronics
5th Jul 20224:41 pmRNSSecond Price Monitoring Extn
5th Jul 20224:35 pmRNSPrice Monitoring Extension
5th Jul 20222:06 pmRNSSecond Price Monitoring Extn
5th Jul 20222:01 pmRNSPrice Monitoring Extension
4th Jul 20224:43 pmRNSReplacement: Trading Update
1st Jul 20222:09 pmRNSHolding(s) in Company
30th Jun 202212:11 pmRNSResult of AGM
30th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSPosting of Annual Report & Notice of AGM
30th May 20227:00 amRNSFinal Results
19th Apr 20227:00 amRNSManufacturing Services Framework Agreement
28th Mar 20227:30 amRNSUpdate on Microsaic's miniaturised technology
15th Mar 20227:00 amRNSBoard Appointment and Strategic Update
8th Mar 20224:35 pmRNSPrice Monitoring Extension
7th Mar 20222:05 pmRNSSecond Price Monitoring Extn
7th Mar 20222:00 pmRNSPrice Monitoring Extension
21st Feb 20221:31 pmRNSHolding(s) in Company
17th Feb 20222:45 pmRNSHolding(s) in Company
16th Feb 202211:06 amRNSSecond Price Monitoring Extn
16th Feb 202211:00 amRNSPrice Monitoring Extension
14th Feb 20227:00 amRNSDirector Dealing, Issue of Equity and TVR
28th Jan 20227:00 amRNSResignation of Chief Executive Officer
12th Jan 20224:43 pmRNSHolding(s) in Company
10th Jan 20223:30 pmRNSInvestor Presentation
10th Jan 20227:00 amRNSTrading Update
7th Jan 20222:06 pmRNSSecond Price Monitoring Extn
7th Jan 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20217:00 amRNSFurther order from DeepVerge
12th Nov 20217:00 amRNSNew compact screening platform
5th Nov 202110:12 amRNSHolding(s) in Company
27th Oct 20217:00 amRNSLaunch of technology for scaling drug manufacture
22nd Oct 20217:00 amRNSBoard Change
21st Oct 20217:00 amRNSUpdate on DeepVerge Collaboration
28th Sep 20214:30 pmRNSHolding(s) in Company
27th Sep 20217:00 amRNSInterim Results
24th Sep 20217:00 amRNSSigning of agreement to support China operations
22nd Sep 202111:06 amRNSNotice of Results and Investor Presentation
27th Aug 20214:40 pmRNSSecond Price Monitoring Extn
27th Aug 20214:35 pmRNSPrice Monitoring Extension
23rd Aug 20217:00 amRNSDeepVerge Collaboration for Water & Soil Analysis
9th Aug 20217:00 amRNSHeads of Terms signed with manufacturer in China
6th Jul 202111:55 amRNSInvestor Presentation
6th Jul 20217:00 amRNSTrading update for H1 2021
5th Jul 20219:50 amRNSHolding(s) in Company
2nd Jul 20217:00 amRNSDevelopment of real-time monitoring solution
17th Jun 202110:54 amRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.